XT2 is a highly potent, orally active, and selective inhibitor of NF-kappaB-inducing kinase (NIK), exhibiting an IC50 of 9.1 nM. It effectively suppresses the upregulation of ALT, a vital biomarker for acute liver injury, induced by CCl4. Additionally, XT2 significantly decreases immune cell infiltration into the damaged liver tissue. As a result, XT2 holds immense potential in liver inflammatory disease research [1].
Molekulargewicht:
379.41
CAS Nummer:
[2582816-37-1]
Formel:
C19H14FN5OS
Target-Kategorie:
Others|||NF-kappaB
T61599
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten